Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥504.02 Million ≈ $73.75 Million USD) by net assets (CN¥9.15 Billion ≈ $1.34 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Chengdu Kanghong Pharmaceuticals Group C worth for the company's overall valuation and market capitalisation.
Chengdu Kanghong Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Chengdu Kanghong Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chengdu Kanghong Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency. Explore Chengdu Kanghong Pharmaceuticals Group C cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eternal Materials Co Ltd
TW:1717
|
0.042x |
|
Zhejiang Shenghua Biok Biology Co Ltd
SHG:600226
|
0.021x |
|
Corporación Inmobiliaria Vesta, S.A.B de C.V.
NYSE:VTMX
|
0.019x |
|
BSP Financial Group Ltd
AU:BFL
|
0.103x |
|
Sportradar Group AG
NASDAQ:SRAD
|
0.150x |
|
Shufersal
TA:SAE
|
0.144x |
|
Ansell Limited
F:PD1A
|
0.031x |
|
CLARIANT ADR 1/SF 4
F:CLRS
|
N/A |
Annual Cash Flow Conversion Efficiency for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
The table below shows the annual cash flow conversion efficiency of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. View Chengdu Kanghong Pharmaceuticals Group C (002773) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥9.27 Billion ≈ $1.36 Billion |
CN¥1.50 Billion ≈ $220.03 Million |
0.162x | -0.71% |
| 2024-12-31 | CN¥8.65 Billion ≈ $1.27 Billion |
CN¥1.41 Billion ≈ $206.60 Million |
0.163x | +4.69% |
| 2023-12-31 | CN¥7.81 Billion ≈ $1.14 Billion |
CN¥1.22 Billion ≈ $178.29 Million |
0.156x | +16.44% |
| 2022-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
CN¥925.15 Million ≈ $135.38 Million |
0.134x | +65.50% |
| 2021-12-31 | CN¥6.10 Billion ≈ $893.35 Million |
CN¥494.11 Million ≈ $72.30 Million |
0.081x | +70.45% |
| 2020-12-31 | CN¥5.76 Billion ≈ $842.26 Million |
CN¥273.32 Million ≈ $39.99 Million |
0.047x | -72.98% |
| 2019-12-31 | CN¥4.62 Billion ≈ $676.13 Million |
CN¥812.15 Million ≈ $118.84 Million |
0.176x | +104.58% |
| 2018-12-31 | CN¥4.08 Billion ≈ $597.61 Million |
CN¥350.88 Million ≈ $51.35 Million |
0.086x | -60.30% |
| 2017-12-31 | CN¥3.54 Billion ≈ $518.52 Million |
CN¥766.86 Million ≈ $112.22 Million |
0.216x | -25.72% |
| 2016-12-31 | CN¥2.90 Billion ≈ $425.08 Million |
CN¥846.35 Million ≈ $123.85 Million |
0.291x | +52.64% |
| 2015-12-31 | CN¥2.52 Billion ≈ $369.49 Million |
CN¥481.97 Million ≈ $70.53 Million |
0.191x | +5.59% |
| 2014-12-31 | CN¥1.61 Billion ≈ $235.85 Million |
CN¥291.38 Million ≈ $42.64 Million |
0.181x | -24.65% |
| 2013-12-31 | CN¥1.39 Billion ≈ $203.30 Million |
CN¥333.31 Million ≈ $48.77 Million |
0.240x | -5.84% |
| 2012-12-31 | CN¥1.11 Billion ≈ $161.87 Million |
CN¥281.84 Million ≈ $41.24 Million |
0.255x | +41.29% |
| 2011-12-31 | CN¥936.39 Million ≈ $137.02 Million |
CN¥168.86 Million ≈ $24.71 Million |
0.180x | -17.63% |
| 2010-12-31 | CN¥624.85 Million ≈ $91.44 Million |
CN¥136.79 Million ≈ $20.02 Million |
0.219x | +8.98% |
| 2009-12-31 | CN¥539.75 Million ≈ $78.98 Million |
CN¥108.42 Million ≈ $15.87 Million |
0.201x | -- |
About Chengdu Kanghong Pharmaceuticals Group Co Ltd
Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.